Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J73-003 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585 |
filingDate |
2011-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2013-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2013527248-A |
titleOfInvention |
Treatment of cancer with wortmannin analogs |
abstract |
Specific therapeutically effective dosing regimens for the treatment of cancer with wortmannin analogs are provided herein. [Selection] Figure 1 |
priorityDate |
2010-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |